Product correctly added to cart.

No image
No image

United States Pharmacopoeia (USP) Solutions and Reagents

United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.

Read more

Subcategories of "United States Pharmacopoeia (USP) Solutions and Reagents"

Products of "United States Pharmacopoeia (USP) Solutions and Reagents"

Sort by


See more categories

This search does not contain any category.

products per page. 6737 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
Pseudoephedrine Sulfate
REF: 45-1581504
CAS: 7460-12-0
- - -To inquireTue 04 Feb 25
Buprenorphine System Suitability Mixture CII (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine)
REF: 45-1078722
- - -To inquireTue 04 Feb 25
Exemestane Related Compound C CIII (androsta-1,4-diene-3,17-dione)
REF: 45-1269083
CAS: 897-06-3
- - -To inquireTue 04 Feb 25
Oxycodone CII
REF: 45-1485191
CAS: 76-42-6
- - -To inquireTue 04 Feb 25
Nordazepam CIV (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
REF: 45-1468400
CAS: 1088-11-5
- - -To inquireTue 04 Feb 25
Chlordiazepoxide Hydrochloride CIV
REF: 45-1110009
CAS: 438-41-5
- - -To inquireTue 04 Feb 25
Methylnaltrexone Peak Identification Mixture CII (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A)
REF: 45-1430724
- - -To inquireTue 04 Feb 25
Buprenorphine Related Compound A CII ((S)-2-[17-(But-3-en-1-yl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethanomorphinan-7α-yl]- 3,3-dimethylbutan-2-ol)
REF: 45-1078711
CAS: 457071-73-7
- - -To inquireTue 04 Feb 25
Phenobarbital CIV
REF: 45-1524001
CAS: 50-06-6
- - -To inquireTue 04 Feb 25
Norethindrone Related Compound B CIII (Estr-4-ene-3,17-dione)
REF: 45-1470026
CAS: 734-32-7
- - -To inquireTue 04 Feb 25
Testosterone Enanthate Related Compound B CIII (Androst-4-en-3-one-17β-yl hexanoate)
REF: 45-1648026
CAS: 10312-45-5
- - -To inquireTue 04 Feb 25
Oxandrolone Related Compound A CIII (17β-hydroxy-17α-methyl-2-oxa-5α-androst-7-en-3-one)
REF: 45-1482014
CAS: 1391052-43-9
- - -To inquireTue 04 Feb 25
Dextromethorphan Related Compound A CI (3-Methoxy-9α,13α,14α-morphinan hydrochloride)
REF: 45-1180514
CAS: 1087-69-0
- - -To inquireTue 04 Feb 25
Morphine Related Compound B CII (2,2'-Bimorphine trihydrate)
REF: 45-1448027
CAS: 6472-73-7
- - -To inquireTue 04 Feb 25
Alfentanil Hydrochloride CII
REF: 45-1012906
CAS: 70879-28-6
- - -To inquireTue 04 Feb 25
Dextroamphetamine Sulfate CII
REF: 45-1180004
CAS: 51-63-8
- - -To inquireTue 04 Feb 25
Sodium Fluoride
REF: 45-1614002
CAS: 7681-49-4
- - -To inquireTue 04 Feb 25
Midazolam Hydrochloride CIV
REF: 45-1443602
CAS: 59467-96-8
- - -To inquireTue 04 Feb 25
Brivaracetam CV
REF: 45-1078030
CAS: 357336-20-0
- - -To inquireTue 04 Feb 25
Oxycodone Related Compound B CII (oxycodone N-oxide)
REF: 45-1485227
CAS: 71539-52-1
- - -To inquireTue 04 Feb 25
discount label

Pseudoephedrine Sulfate

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Buprenorphine System Suitability Mixture CII (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Exemestane Related Compound C CIII (androsta-1,4-diene-3,17-dione)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Oxycodone CII

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Nordazepam CIV (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Chlordiazepoxide Hydrochloride CIV

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Methylnaltrexone Peak Identification Mixture CII (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Buprenorphine Related Compound A CII ((S)-2-[17-(But-3-en-1-yl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethanomorphinan-7α-yl]- 3,3-dimethylbutan-2-ol)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Phenobarbital CIV

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Norethindrone Related Compound B CIII (Estr-4-ene-3,17-dione)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Testosterone Enanthate Related Compound B CIII (Androst-4-en-3-one-17β-yl hexanoate)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Oxandrolone Related Compound A CIII (17β-hydroxy-17α-methyl-2-oxa-5α-androst-7-en-3-one)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Dextromethorphan Related Compound A CI (3-Methoxy-9α,13α,14α-morphinan hydrochloride)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Morphine Related Compound B CII (2,2'-Bimorphine trihydrate)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Alfentanil Hydrochloride CII

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Dextroamphetamine Sulfate CII

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Sodium Fluoride


Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Midazolam Hydrochloride CIV

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Brivaracetam CV

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
discount label

Oxycodone Related Compound B CII (oxycodone N-oxide)

Controlled Product
Estimated delivery in United States, on Tuesday 4 Feb 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".